RxDestruct Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $800K
Latest Deal Amount
  • Investors
  • 3

RxDestruct General Information


Developer of a waste management systems designed to allow hospitals and nursing homes to dispose of their pharmaceutical waste safely and conveniently. The company's product helps in neutralizing the active compounds in unused medications so they can be disposed of easily without polluting water supplies, enabling hospitals to ensure pharmaceutical waste stays out of the environment and does not contribute to the current opioid epidemic sweeping the country.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Commercial Products
Other Industries
Water Utilities
Environmental Services (B2B)
Primary Office
  • 126 North Smythe Avenue
  • Edmond, OK 73034
  • United States
+1 (832) 000-0000

RxDestruct Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RxDestruct Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 03-Jun-2020 $800K 00.000 Completed Generating Revenue
4. Later Stage VC (Series A) 30-Nov-2017 00.000 00.000 Completed Startup
3. Angel (individual) 24-Oct-2013 00000 Completed Startup
2. Angel (individual) 14-Nov-2011 $342K $342K Completed Startup
1. Accelerator/Incubator Completed Startup
To view RxDestruct’s complete valuation and funding history, request access »

RxDestruct Executive Team (3)

Name Title Board Seat Contact Info
Mark Macdonell Co-Founder, Chief Executive Officer & Board Member
Thomas Stern Co-Founder & Executive Vice President of Sales
To view RxDestruct’s complete executive team members history, request access »

RxDestruct Board Members (6)

Name Representing Role Since
Chris Cuzalina Self Board Member & Advisor 000 0000
Chris Quinn RxDestruct Board Member 000 0000
Mark Macdonell RxDestruct Co-Founder, Chief Executive Officer & Board Member 000 0000
Michael Sanborn RxDestruct Board Member 000 0000
Scott Kosch RxDestruct Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

RxDestruct Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RxDestruct Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
i2E Venture Capital Minority 000 0000 000000 0
Scott Kosch Angel (individual) Minority 000 0000 000000 0
Insight Accelerator Labs Accelerator/Incubator 000 0000 000000 0
To view RxDestruct’s complete investors history, request access »